Dr. David Hardisson obtained his M.D. and Ph.D. (with the Extraordinary Doctorate Award) from the University of Oviedo in Spain. He completed his residency in Anatomic Pathology at the University Hospital La Paz in Madrid, where he currently serves as Head of Department. He has over 20 years of experience in breast and gynecologic pathology. From 2008 to 2020, he served as Assistant Professor of Pathology at the Universidad Autónoma de Madrid, and since December 2020, he has been appointed as Full Professor of Pathology at the same institution. Dr. Hardisson is a member of the Spanish Society of Pathology, the European Society of Pathology, the United States and Canadian Academy of Pathology (USCAP), and the International Society of Gynecological Pathologists. His research interests are primarily focused on the molecular basis of breast and gynecologic cancer, and he is Principal Investigator and Director of the research group of Molecular Pathology of Cancer and Therapeutic Targets at the Hospital La Paz Institute for Health Research (IdiPAZ). Dr. Hardisson holds a Master's in Molecular Oncology from the National Cancer Research Center (CNIO) and the European School of Oncology, is a Diplomate in "Cellular Growth and Cancer" from the National University of Distance Education (UNED), and is a Diplomate of the European Board of Pathology. Dr. Hardisson has authored over 160 peer-reviewed papers and has participated in numerous national and international courses and congresses.